• 제목/요약/키워드: Kidney Cancer

검색결과 363건 처리시간 0.028초

신장이식 환자의 수술 후 경과기간에 따른 미충족요구 분석 (Analysis of Unmet needs by Elapsed Time in Kidney Transplantation Patients)

  • 노세희;박정숙
    • 한국융합학회논문지
    • /
    • 제11권12호
    • /
    • pp.457-467
    • /
    • 2020
  • 본 연구는 지속적인 자가간호가 필요한 신장이식 수술환자의 경과 기간에 따른 미충족 요구를 파악하여, 시기에 맞는 통합적인 간호중재 프로그램 개발에 필요한 기초자료를 제공하고자 시도되었다. 연구대상은 신장이식 수술 후 1년까지 입원 및 외래환자 84명으로 구성되었다. 자료수집 기간은 2020년 2월 17일부터 5월 31일까지로, Comprehensive Needs Assessment Tool in Cancer(CNAT)를 신장이식 환자에 맞게 수정·보완, 전문가 타당도 검증을 거쳐 사용하였다. 자료분석은 Chi-square, 독립 t-test, one-way ANOVA, ANCOVA, 사후검정은 Scheffé로 하였다. 연구결과 신장이식 수술 환자의 미충족 요구는 171점 만점 중 총점 평균 68.28(±38.88)점, 하부영역 8개 중 정보 및 교육이 17.92(±8.36)점으로 가장 높았다. 경과 기간에 따른 미충족 요구는 3-6개월에 비해 6개월-1년까지가 유의하게 높았다(F=7.57, p=.001). 이를 토대로 신이식 후 회복이 되어 관심이 줄어들 수 있는 6개월-1년 사이 환자의 미충족 요구는 증가하였으므로 적절한 정보와 도움을 융합하여 제공하는 간호중재 프로그램이 필요하다.

Kidney-sparing Management Versus Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Systematic Review and Meta-analysis

  • Luo, You;She, Dong-Li;Xiong, Hu;Fu, Sheng-Jun;Yang, Li
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권14호
    • /
    • pp.5907-5912
    • /
    • 2015
  • Purpose: To evaluate and update evidence for prognostic effects of kidney-sparing (KS) management and nephroureterectomy (NU) for upper tract urothelial carcinomas. Materials and Methods: Pubmed, Embase and the Cochrane Library were retrieved for the identification of comparative studies of kidney-sparing procedure and nephroureterectomy for upper tract urothelial carcinoma prior to December 2014. The data were extracted independently by 2 reviewers and the quality of the included studies was assessed. Review Manager 5.3 and STATA 13 were used to perform the meta-analysis. Results: Twenty-three observational studies including 1,587 KS and 3,996 NU were evaluated. The results of the meta-analysis showed that nephroureterectomy had no significant benefit with regard to intravesical recurrence (IRFS), metastasis (MFS), cancer specific survival (CSS) and overall survival (OS) except the total tumor recurrence (RFS) when compared with kidney sparing management. The respectively pooled outcomes were HR 1.36 (0.69-2.68, P=0.38) for IRFS, 1.09 (0.59-2.01, P=0.78) for MFS, 1.17 (0.77-1.79, P=0.47) for CSS, 1.50 (0.90-2.48, P=0.12) for OS and 1.61 (1.03-2.51, P=0.04) for RFS. Conclusions: On the whole, kidney-sparing management had equivalent prognostic effect on upper tract urothelial carcinoma as the standard nephroureterectomy except in tumor recurrence. However, the results should be interpreted with caution for lack of stage and grade stratification and multi-center randomized controlled trials are still needed to verify our results.

흡연과 암 (Smoking and Cancer: a Review of the Recent Evidence)

  • 김남득;전성실
    • 한국환경성돌연변이발암원학회지
    • /
    • 제18권1호
    • /
    • pp.9-14
    • /
    • 1998
  • By far, the largest known preventable cause of cancer is cigarette smoking. The percentage of cancer deaths in Korea due to tobacco is still increasing. Smoking cigarette at an early age has become more common among women. Tobacco consumption is related causally to cancer to the lung, mouth, larynx, esophagus, bladder, kidney, uterine cervix, and pancreas. Recently, several studies demonstrated that there is very strong correlation between cigarette smoking and p53 mutations in lung cancer, head and neck cancer, and bladder cancer. The recent findings of cigarette smoking and cancer, p53 and bcl-2 mutations, adverse effects of smoking on the effects of radiotherapy, and benefits of quitting will be discussed.

  • PDF

P53 and MDM2 Over-expression and Five-year Survival of Kidney Cancer Patients Undergoing Radical Nephrectomy - Iranian Experience

  • Abolhasani, Maryam;Salarinejad, Sareh;Asgari, Mojgan
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권12호
    • /
    • pp.5043-5047
    • /
    • 2015
  • Background: Relatively little is known with certainty about the status and role of p53 or MDM2 in predicting prognosis and survival of renal cell carcinoma. The present study aimed to determine the value of P53 and MDM2 over-expression, alone and simultaneously, to predict five-year survival of patients with kidney cancer in Iran. Materials and Methods: Patients with kidney cancer referred to Hasheminejad Kidney Center between 2007 and 2009, underwent radical nephrectomy and had pathology reports of clear cell, papillary or chromophobe renal cell carcinoma were included in our cohort study. Other histological types of renal cell carcinoma were not included. The patients with missed, incomplete or poor quality paraffin blocks were also excluded. Overall ninety one patients met the inclusion and exclusion criteria. To assess the histopathological features of the tumor, immunohistochemical (IHC) staining of formalin fixed, paraffin-embedded tumor samples were performed. The five-year survival was determined by the patients' medical files and telephone following-up. Results: In total, 1.1% of all samples were revealed to be positive for P53. Also, 20.8% of all samples were revealed to be positive for MDM2.The patients were all followed for 5 years. In this regard, 5-year mortality was 30.5% and thus 5-year survival was 85.3%. According to the Cox proportional hazard analysis, positive P53 marker was only predictor for patients' 5-year survival that the presence of positive p53 increased the risk for long-term mortality up to 2.8 times (HR=2.798, 95%CI: 1.176-6.660, P=0.020). However, the presence of MDM2 could not predict long-term mortality. In this regard, analysis by the ROC curve showed a limited role for predicting long-term survival by confirming P53 positivity (AUC=0.610, 95%CI: 0.471-.750, P=0.106). The best cutoff point for P53 to predict mortality was 0.5 yielding a low sensitivity (32.0%) but a high specificity (97.9%). In similar analysis, measurement of MDM2 positivity could not predict mortality (AUC=0.449, 95%CI: 0.316-.583, P=0.455). Conclusions: The simultaneous presence of both P53 and MDM2 markers in our population is a rare phenomenon and the presence of these markers may not predict long-term survival in patients who undergoing radical nephrectomy.

Inhibition of proliferation of human breast cancer cell (SK-BR3) and liver cancer cell(SK-Hepl) in tissue culture by the CCCA from Cordyceps militaris

  • Lee, Seung-Jeong;Han, Shin-Ha;Park, Eun-Jung;Lee, Chong-Kil;You, Byeong-Jin;Cho, Kyung-Hee;Ha, Nam-Joo;Kim, Kyung-Jae
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2003년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.2-2
    • /
    • pp.140.1-140.1
    • /
    • 2003
  • Permanent cell culture lines derived from human cancer tissue are important experimental models in the study of human cancer cell proliferation. The in vitro effects of C. militaris and its extracted fractions on the human breast cancer (SK-BR3), liver cancer (SK-Hep1, HepG2), kidney cancer (p15), lymphoma (Jurkat) were studied. F1 (CCCA, crude cordycepin containing adenosine), F2 (ethanol precipitation), F3 (ethanol soluble supernatant) and F4 (fraction of through SK-1B) significantly stimulated in vitro cytotoxic in human cancer cell lines. (omitted)

  • PDF

간이식 환자의 뇌경색에 대한 한의학적 치료 증례보고 (Case report of The liver transplant patient's cerebral infarction treated with Korean Medicine)

  • 박상은
    • 대한한의학방제학회지
    • /
    • 제24권3호
    • /
    • pp.225-231
    • /
    • 2016
  • Objectives : Liver cancer usually appears in the setting of underlying liver disease. Liver transplantation has potentials to improve survival for patients with liver cancer. This case report was designed to assess the clinical effect of Korean medicine on liver transplant patient's cerebral infarction.Methods : We provided Chiganpung Granule(Chodeungsan) to a patient who was 58 year old man complained of cognitive impairment and dysarthria. We checked the change of symptoms(K-MMSE, Aphasia Rapid Test) and liver function test and kidney function test.Results : We observed that Chiganpung Granule(Chodeungsan) decreased cognitive impairment and dysarthria. Liver function test and Kidney function test was improved.Conclusions : From the above results, it is considered that Korean medicine treatments is effective on liver transplant patient's cerebral infarction.